Efficacy of Conbercept in the Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia

Efficacy of Conbercept in the Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia

Purpose: To observe the clinical efficacy of conbercept in the treatment of choroidal neovascularization (CNV) secondary to pathologic myopia.Methods: We used retrospective analysis of the clinical data of 20 patients (24 eyes) with pathologic myopia choroidal neovascularization (PM-CNV). All patien...

Full description

Bibliographic Details
Main Authors: Hui Lu, Tao Yue, Na Liu, Zuo-Fen Wang, Gai-Xia Zhai, Dong-Ming Mi, Jing Zhang, Shao-Peng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Medicine
Subjects:
conbercept
vascular endothelial growth factor
choroidal neovascularization
pathologic myopia
efficacy
VEGF receptor fusion protein
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.720804/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.720804/full

Similar Items